Trials / Completed
CompletedNCT04680039
Early Warning of Intradialytic Hypotension in Hemodialysis Patients
Noninvasive Hemodynamic Parameters Measurements as a Tool for Early Warning of Intradialytic Hypotension in Hemodialysis Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (actual)
- Sponsor
- Biobeat Technologies Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 120 Years
- Healthy volunteers
- Not accepted
Summary
In this study, the investigators will monitor patients undergoing hemodialysis treatment with a non-invasive wearable PPG-based device. Measurements will include blood pressure, heart rate, oxygen saturation, stroke volume, cardiac output, cardiac index and systemic vascular resistance, among others. The aim is to diagnose intradialytic hypotension more rapidly than with current noninvasive methods and prevent related poor outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Continuous monitoring | Identifying intradialytic hypotension using a PPG-based wearable monitor |
Timeline
- Start date
- 2021-01-15
- Primary completion
- 2022-02-15
- Completion
- 2022-03-15
- First posted
- 2020-12-22
- Last updated
- 2022-07-20
Locations
1 site across 1 country: Israel
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04680039. Inclusion in this directory is not an endorsement.